Ekso Bionics Holdings, Inc. (EKSO)

$ 3.9
-0.18 (-4.41%)
Symbol EKSO
Price $ 3.9
Beta 2.033
Volume Avg. 0.11M
Market Cap 0.05B
Shares () -
52 Week Range 3.88-14.98
1y Target Est -
DCF Unlevered EKSO DCF ->
DCF Levered EKSO LDCF ->
ROE -27.55% Sell
ROA -12.21% Sell
Operating Margin -
Debt / Equity 32.12% Neutral
P/E -
P/B 1.23 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest EKSO news

Mr. Jack Peurach
Medical Instruments & Supplies
Nasdaq Capital Market

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.